Long Non-coding RNA LincRNA-erythroid Prosurvival (EPS) Alleviates Cerebral Ischemia/reperfusion Injury by Maintaining High-temperature Requirement Protein A1 (Htra1) Stability Through Recruiting Heterogeneous Nuclear Ribonucleoprotein L (HNRNPL)
Overview
Authors
Affiliations
This study aimed at investigating the role and mechanism of lincRNA-EPS (erythroid prosurvival) in cerebral ischemia/reperfusion (CIR) injury. The results showed that the overexpression of lincRNA-EPS was able to reduce the levels of interleukin-6, tumor necrosis factor-alpha and interleukin-1β stimulated in the OGD-treated Neuro-2a (N-2a) cells. The levels of reactive oxygen species and malondialdehyde were enhanced while the superoxide dismutase levels were reduced by oxygen and glucose deprivation (OGD) treatment, in which the lincRNA-EPS overexpression could reverse this effect in the cells. LincRNA-EPS interacted with high-temperature requirement protein A1 (Htra1) and heterogeneous nuclear ribonucleoprotein L (HNRNPL), and their depletion inhibited the Htra1 mRNA stability in N-2a cells. HNRNPL knockdown blocked lincRNA-EPS overexpression-induced Htra1 expression in the cells. The depletion of Htra1 could rescue lincRNA-EPS overexpression-mediated N-2a cell injury, inflammation, and oxidative stress induced by OGD. Functionally, lincRNA-EPS alleviates CIR injury of the middle cerebral artery occlusion/reperfusion mice . In conclusion, lincRNA-EPS attenuates CIR injury by maintaining Htra1 stability through recruiting HNRNPL.
Hu A, Xiao F, Wu W, Xu H, Su J Cell Prolif. 2023; 57(1):e13539.
PMID: 37710420 PMC: 10771112. DOI: 10.1111/cpr.13539.
Li Y, Zhang S, Tang L, Feng J, Jia J, Chen Y J Pers Med. 2023; 13(4).
PMID: 37109017 PMC: 10143835. DOI: 10.3390/jpm13040631.
Liu L, Hu L, Long H, Zheng M, Hu Z, He Y Clin Transl Med. 2022; 12(12):e1117.
PMID: 36447054 PMC: 9708910. DOI: 10.1002/ctm2.1117.